450
Participants
Start Date
June 30, 2011
Primary Completion Date
April 30, 2012
Study Completion Date
May 31, 2012
Placebo
Placebo vaginal suppository
DHEA
Vaginal suppository containing 0.25% (3.25 mg) DHEA
DHEA
Vaginal suppository containing 0.5% (6.5 mg) DHEA
EndoCeutics site # 61, Newark
EndoCeutics site # 03, Norfolk
EndoCeutics site # 23, Sandy Springs
EndoCeutics site # 26, Jacksonville
EndoCeutics site # 54, North Miami
EndoCeutics site # 60, Lake Worth
EndoCeutics site # 56, Pinellas Park
EndoCeutics site # 39, Montgomery
EndoCeutics site # 63, Memphis
EndoCeutics site # 64, Jackson
EndoCeutics site # 15, Columbus
EndoCeutics site # 33, Beachwood
EndoCeutics site # 05, Cleveland
EndoCeutics site # 47, Cleveland
EndoCeutics site # 55, Wichita
EndoCeutics site # 24, Omaha
EndoCeutics site # 65, Little Rock
EndoCeutics site # 53, San Antonio
EndoCeutics site # 36, Denver
EndoCeutics site # 52, Denver
EndoCeutics site # 10, Meridian
EndoCeutics site # 51, Sandy City
EndoCeutics site # 09, West Jordan
EndoCeutics site # 14, Tucson
EndoCeutics site # 30, San Diego
EndoCeutics site # 21, Sacramento
EndoCeutics site # 66, Danbury
EndoCeutics site # 42, Milford
EndoCeutics site # 57, West Hartford
EndoCeutics site # 27, Baltimore
EndoCeutics site # 50, Neptune City
EndoCeutics site # 62, Providence
EndoCeutics site # 13, Calgary
EndoCeutics site # 06, Bathurst
EndoCeutics site # 59, Toronto
EndoCeutics site # 04, Drummondville
EndoCeutics site # 12, Montreal
EndoCeutics site # 02, Québec
EndoCeutics site # 01, Québec
EndoCeutics site # 18, Saint Romuald
EndoCeutics site # 08, Shawinigan
EndoCeutics site # 11, Sherbrooke
Lead Sponsor
EndoCeutics Inc.
INDUSTRY